Email: cspc@cspc.cn
News
July 30, 2025
Share:
Previous: VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF SEMAGLUTIDE INJECTION
Next: MESALAZINE ENTERIC-COATED TABLETS OBTAIN DRUG REGISTRATION APPROVAL
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us